Nexmezol (Esomeprazole)

Esomeprazole, the active ingredient in Nexmezol, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to manage conditions such as gastro‑oesophageal reflux disease and ulcer‑related disorders in adult patients. GNH USA supplies Nexmezol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Esomeprazole is indicated for several gastrointestinal acid‑related conditions, acting to lower gastric acidity and promote mucosal healing. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining a higher gastric pH. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - NSAID‑induced gastric ulcer: protects the gastric lining from ulceration caused by non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Adverse reactions may occur with esomeprazole therapy. Most are mild and transient, but some can be serious.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, usually self‑limiting. - Nausea: occasional upset stomach. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating esomeprazole, consider the following safety measures. - Assess renal function: adjust use in severe renal impairment. - Evaluate hepatic status: use cautiously in liver disease. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term therapy: consider periodic assessment of bone health and magnesium levels. - Pregnancy and lactation: discuss risks with a healthcare professional. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Esomeprazole may alter the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Digoxin: possible increase in serum levels, observe for toxicity. - Methotrexate (high dose): increased exposure, check renal function.